Art

J-GLOBAL ID：200902201054416412   Reference number：06A0649842

Treatment Strategy for Advanced Prostate Cancer with Bone Metastases

がん骨転移の治療戦略 前立腺癌骨転移に対する治療戦略

Author (2)： SUGIMOTO MIKIO (香川大 医 泌尿器・副腎・腎移植外科) ,  KAKEHI YOSHIYUKI (香川大 医 泌尿器・副腎・腎移植外科)
Material： 癌と化学療法  (Japanese Journal of Cancer and Chemotherapy)
Volume： 33  Issue： 8  Page： 1065-1071  Publication year： Aug. 15, 2006 
JST Material Number： Z0938A  ISSN： 0385-0684  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： prostatic tumor ,...
Semi thesaurus term： follicular hormone ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=06A0649842&from=J-GLOBAL&jstjournalNo=Z0938A") }}

JST classification (3)： Urogenital tumors(=neoplasms)  (GM04000S) ,  Tumors(=neoplasms)of musculoskeletal system  (GG04000A) ,  Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N)

Reference (27)：

• Claude S: 前立腺癌の骨転移とビスホスホネートの役割. 泌尿器外科 18(3): 263-273, 2005.
• Jacek P, Tanya B and Dorff: Prostate cancer metastasis to bone: Pathophysiology, pain management, and the promise of targeted therapy. Eur J Cancer 41: 932-940, 2005.
• Drobnjak M, Osman I, Scher HI, et al: Overexpression of cyclin D 1 is associated with metastatic prostate cancer. Clin Cancer Res 6: 1891-1895, 2000.
• Lorente JA, Valenzuela H, Morote J, et al: Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients. Eur J Nucl Med 26: 625-632, 1999.
• Kylmala T, Tammela TL, Risteli L, et al: Type I collagen degradation product (I CTP) gives information about the nature of bone metastasis and has prognosis value in prostate cancer. Br J Cancer 71: 1061-1064, 1995.

Terms in the title (4)： がん ,  骨転移 ,  治療戦略 ,  前立腺癌